Skip to main content
SpringerLink
Log in

Bevacizumab/tipiracil/trifluridine

Febrile neutropenia, thrombocytopenia and vomiting: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Naito A, et al. Case Series of the TAS-102 plus Bevacizumab(Bev)Combination Therapy in Unresectable Advanced Colorectal Cancer. Gan to Kagaku Ryoho 47: 2104-2106, No. 13, Dec 2020. Available from: URL: https://pubmed.ncbi.nlm.nih.gov/33468875/ [Japanese; summarised from a translation]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bevacizumab/tipiracil/trifluridine. Reactions Weekly 1843, 80 (2021). https://doi.org/10.1007/s40278-021-91182-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-91182-z

Search

Navigation